Related Experiment Video
Updated: Sep 14, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Blocking of CDC25B suppresses sarcoma progression via arresting cell cycle
Renqin Lin1,2,3, Jianhua Lin1,2,3
1Department of Orthopedics, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Background:
Soft tissue sarcoma is a malignant tumor originating from mesenchymal tissue, accounting for approximately 1% of adult malignancies. Cell division cycle protein 25B (CDC25B) plays a crucial role in human diseases, however, its function in soft tissue sarcoma remains poorly understood. This study aims to explore the prognostic and therapeutic values of CDC25B in sarcoma.
Methods:
The expression and prognostic values of CDC25B in sarcoma were analyzed using bioinformatics approaches. Additionally, a CDC25B inhibitor (CDC25B-IN-1) was used to evaluate the potential therapeutic value of the CDC25B target using Cell Counting Kit-8 (CCK-8), quantitative polymerase chain reaction (qPCR) detection, 5-ethynyl-2'-deoxyuridine (EdU), colony formation, transwell, wound healing, flow cytometry and western blot (WB) assays.
Results:
The bioinformatics analysis found that CDC25B is overexpressed in sarcoma tissues, and high expression of CDC25B correlated with lower disease-specific survival (DSS), progress-free interval (PFI), and overall survival (OS). The univariate and multivariate analysis identified CDC25B as an independent prognostic biomarker in sarcoma. Experimental validation demonstrated that blocking CDC25B using CDC25B inhibitor (CDC25B-IN-1) can suppress sarcoma progression by inducing G2 cell cycle arrest.
Conclusions:
CDC25B is highly expressed in sarcoma, and blocking of CDC25B can suppress sarcoma progression by inducing G2 cell cycle arrest. These findings suggest that CDC25B may serve as a potential molecular biomarker and therapeutic target for sarcoma.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Negative Regulator Molecules
Anaphase Promoting Complex
DNA Damage can Stall the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

